| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $46.3M | -0.2% | -28.0% |
| R&D Expense | $2.5M | -10.5% | -2.1% |
| SG&A Expense | $12.7M | +19.2% | -13.4% |
| Operating Income | -$6.0M | -72.7% | -267.3% |
| Pre-tax Income | -$7.8M | +24.5% | -518.3% |
| Income Tax | -$346K | -203.9% | -214.5% |
| Net Income | -$7.4M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $34.3M | +15.4% | -36.2% |
| Accounts Receivable | $33.8M | -5.9% | -31.9% |
| Current Assets | $82.8M | -3.1% | -31.5% |
| Total Assets | $211.2M | +0.4% | -23.6% |
| Current Liabilities | $93.1M | +34.3% | -48.4% |
| Long-term Debt |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$7.0M | — | — |
| Capital Expenditures | $1.7M | — | — |
| Investing Cash Flow | -$11.2M | — | — |
| Financing Cash Flow | $13.5M | — | — |
| Free Cash Flow | -$8.7M | — | — |
| +31.3% |
| -455.9% |
| EPS (Basic) | -$0.20 | +28.6% | -433.3% |
| EPS (Diluted) | -$0.20 | +28.6% | -500.0% |
| $24.3M |
| -36.6% |
| — |
| Total Liabilities | $134.6M | +6.4% | -33.5% |
| Stockholders' Equity | $75.9M | -6.5% | +5.8% |